Here are 5 things individuals should know about the powerful impact of blood donation and the benefits becoming a donor can ...

which examined the use of obinutuzumab in patients with thrombotic thrombocytopenic purpura. Sosa, an associate professor and chief of the division of hematology at Fox Chase Cancer Center ...

The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is also ...

Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells in the body. They differ based on which type of blood cell is ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

Driven by Biopharmaceutical Innovations and Gene Therapies, the market Booms Amidst Growing Incidence of Hemophilia and Von Willebrand Disease ...

Eating disorders are characterized by a persistent disturbance of eating patterns that leads to poor physical and/or psychological health. The major eating disorders are anorexia nervosa ...

Novel treatments for immune thrombocytopenia (ITP) and the place of direct oral anticoagulation in children and adults are among the insights in thrombotic disorders that were presented at the ...

Amid a rapidly evolving macroenvironment, Takeda is changing up its R&D priorities and investment strategy. | “There's an evolution of our economic model that starts with IRA, and will get worse and ...

Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells. Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers ...

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.